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Abstract
Background: Keloids are common benign tumors of the dermis, typically arising after insult to the
skin. While typically only impinging on cosmesis, large or recurrent keloids may require therapeutic
intervention. While no single standardized treatment course has been established, several series
report excellent outcomes for keloids with post-surgery radiation therapy.
Case presentation: We present a patient with a history of recurrent keloids arising in the
absence of an ascribed trauma and a maternal familial history of keloid formation, whose physical
examination several large perineal keloids of 6-20 cm in the largest dimension. The patient was
treated with surgical extirpation and adjuvant radiation therapy. Radiotherapy was delivered to the
scar bed to a total dose of 22 Gy over 11 daily fractions. Acute radiotherapy toxicity necessitated
a treatment break due to RTOG Grade III acute toxicity (moderate ulceration and skin breakdown)
which resolved rapidly during a 3-day treatment break. The patient demonstrated local control and
has remained free of local recurrence for more than 2 years.
Conclusion: Radiotherapy for keloids represents a safe and effective option for post-surgical
keloid therapy, especially for patients with bulky or recurrent disease.
Background
Keloids are benign, common, fibroproliferative dermal
tumors which usually occur as a result of trauma to the
skin[1], though their pathogenesis is distinct from hyper-
trophic scars [2]. Keloids are often refractory to treatment,
recurring frequently. While the precise etiology and
genetic mechanism of this pathology is unknown, keloids
are believed to be more prevalent in patients of African
descent. While most keloids are sporadic, familial keloids
seem to represent an incomplete penetrance autosomal
dominant disease, with varying degrees of clinical severity
within a pedigree [3]. An association with diabetes, which
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was noted in the medical history of our patient and her
maternal line, has also been observed in at least one series
[4]. Additionally, this case is remarkable for the fact that
few keloids form in the female genital region in compari-
son to other high-skin tension regions, for unknown rea-
sons [5]. While not frequently considered as candidates
for oncologic therapies, severe lesions may require radio-
therapy or intralesional injection of interferon and flour-
ouracil in addition to surgical extirpation [2-4]. This case
presents the formation of keloids without recollection of
any recollected traumatic event, notable for their location
and size, in a female patient subsequently treated with
post-surgical radiotherapy.
Case presentation
A 34-year old African-American woman presented with a
giant perineal tumor associated with a 29-year history of
keloid formation without recalled dermal injury or abra-
sion. The patient's history revealed two family members
(a mother and sister) with similar symptomology, result-
ing in a diagnosis of familial keloid syndrome. However,
neither the mother nor sister was affected with perineal
keloid development. Past medical history was also nota-
ble for arthritic symptoms and diabetes mellitus, which
were present in both mother and sister. The index lesion
was firm, pliable growth, 20 cm in its greatest diameter,
adjacent to 10 cm and 6 cm perivulvar lesions, which
caused the patient considerable discomfort and affected
ambulation (Figure 1). Physical examination revealed
multiple other hypertrophic nodular growths on the pos-
terior neck, behind the right ear, bilateral scapular
regions, right flank and breast, abdomen and extremities
in addition to the primary lesion. Past medical history
evinced numerous heterogeneous treatments for various
keloids in multiple loci; she had previously received surgi-
cal extirpation, steroid injections, and two episodes of
radiotherapy to the back. Despite these interventions, her
keloids have either recurred or persisted. Surgical extirpa-
tion of the largest perineal lesion was undertaken, and his-
topathologic examination was performed, denoting the
classic keloid-associated features of haphazard collagen
deposition, with nodular formations thickened hyali-
nized bands (Figure 2).
On the day following surgical excision, the patient was
treated with radiotherapy using photons at 6MV. The total
dose delivered was 22 Gy in 11 days, with a daily fraction
of 2 Gy. The dose fraction was split between two fields
with an anterior-posterior/posterior-anterior (AP/PA)
port arrangement. Maximum acute Radiation Therapy
Oncology Group skin toxicity score was Grade 3 (moder-
ate ulceration and skin breakdown), which resolved after
a 3-day treatment break.
At 6 months post-therapy, the lesion in question had not
recurred (Figure 3), and the patient reported no difficulty
attributable to the lesion.
After 10 months after completion of radiation treatment
for perineal keloids, the patient returned for additional
treatment to her back and chest wall. Radiotherapy was
delivered at 3 Gy/fraction with 9MeV electrons to her
back, lateral back, and anteromedial back over 4 days. No
complications have been noted, and the patient is cur-
rently being followed, with > 24 months since therapy..
Conclusion
Keloids are benign fibroproliferative growths distin-
guished by excessive collagen deposition in the dermis.
The exact etiology of these lesions remains unknown.
They are considered a derailment of the normal wound
healing process with a higher prevalence in darker pig-
mented races.
Keloids are often described as benign fibroproliferative
growths resulting from a connective tissue response to a
variety of insults, such as surgery, burns, trauma, inflam-
Pre-therapy photograph of giant perineal keloid, showing lob- ulated appearance Figure 1
Pre-therapy photograph of giant perineal keloid, showing lob-
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mation, foreign-body reactions, endocrine dysfunction.
However, they occasionally occur without apparent exter-
nal cause. They are characterized by excessive collagen and
glycosaminoglycan deposition within the dermis, an
increase in collagen turnover, and micro-vasculature
regeneration [6,9,10]. Clinically, keloids may not appear
for several months and can be delayed for several years
after initial injury. Minor injuries can produce a fairly
large, deep, and reddish-purple indurated lesion that
rarely subsides. They can range in size from small papules
limited to only a few millimeters in diameter to football
size and larger. Their texture can vary between a soft and
dough-like to a hard and rubbery consistency. These
lesions most commonly affect areas of increased skin ten-
sion. Very rarely, keloids may develop on the palms of the
hands, soles of the feet, and the genitalia [5].
Keloid formation can be found in all ethnicities, but has a
higher predilection for darker pigmented populations.
Why occurrence rates are higher among these groups as
opposed to others is inconclusive. Inheritance patterns
may offer clues as to who could be at a greater risk of being
predisposed to forming these types of lesions. Several
reports have suggested that keloids follow an autosomal
dominant or autosomal recessive inheritance pattern,
although the exact mode of inheritance remains
unknown. Maneros et al. report observing 14 pedigrees
with familial keloids that spanned 3 generations [5].
While most families in the study where African-American,
the report concludes that this may be associated more eth-
nicity rather than skin pigment, since some lighter-
skinned members of the families had the more severe
lesions. Through the use of a genome wide linkage screen,
plausible gene loci for these keloid pedigrees were identi-
fied [6]. Their results found a pattern consistent with an
autosomal dominant mode of inheritance. Subsequent
linkage analysis has revealed two distinct gene loci which
may serve as specific susceptibility genes [11].
In keloid lesions, the therapy chosen is predicated upon
several factors, including: size of lesion, location, depth of
lesion, age of patient, and past response to treatment. Sur-
gical excision, radiation, pressure therapy, cryotherapy,
intralesional injections of corticosteroids, interferon and
fluorouracil, topical silicone and other dressings, and
pulse-dye laser treatment have all been found to induce
some degree of regression [12]. Despite the broad range of
treatment modalities, there is no universally accepted
treatment protocol. In most instances these therapies are
used as an adjuvant to surgical excision.
Radiation therapy has been a rather controversial issue in
keloid treatment. Surgery-alone and adjuvant intrale-
sional corticosteroid approaches exhibit literature
reported recurrence rates of 45-100% and under 50%,
respectively [7]. Comparatively, extant radiotherapy series
have demonstrated recurrence rates which are markedly
better than surgery alone or adjuvant corticosteroid injec-
tion. A brief summary of selected English language series
of teletherapy treatment for keloids are collated in Table
1. However, the only prospective randomized trial of any
Three-month follow-up appearance after surgical excision  and radiotherapy Figure 3
Three-month follow-up appearance after surgical excision 
and radiotherapy.
Low (right)- and high-power histology of excised keloid,  showing characteristic grayish-colored lobular tissue with  fibrous polypoid whorls Figure 2
Low (right)- and high-power histology of excised keloid, 
showing characteristic grayish-colored lobular tissue with 
fibrous polypoid whorls.B
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Table 1: Summary of selected literature (WLE = wide local excision; RT = radiotherapy; Fx = fraction).
Author Subset Pts
.
# Lesions Technique Response rate(%) Total dose
(Gy)
Fx size
(Gy)
Notes/findings
Arnold[13] All 155 179 Superficial X-rays 10–30 2–7 Historical series demonstrates results of RT without surgery
RT only 67 " 81 10–30 2–7
WLE + RT 52 " 79 10–30 2–7
Chaudhry[14] WLE + RT 36 - Superficial X-rays 97 18 3 Series are earlobe keloids only.
Borok[15] WLE + RT 250 393 Superficial X-rays 98 4–16 varied Excellent cosmetic results in 92% of pts; recommended 12 Gy in 3 fx.
Doornbos[3] RT alone/WLE + RT 203 278 Superficial X-rays 74 4.5–18 varied Risk of failure necessitates total dose of at least 9 Gy. 15 pts got definitive 
RT. 9 Gy resulted in 70.4% control rate vs. 36.4% with 6 Gy.
Lo[16] WLE + RT 199 354 Electrons - 2–20 1 Single fraction regimen; local control of 87% receiving doses of 9 Gy or 
greater, vs 43% of 21 receiving less than 9 Gy, though non-significant 
statistically.
Kovalic[17] WLE + RT 75 113 Superficial X-rays 73 10–20 1–5 Mixed treatment cohort; no need to give RT within 24 hours
Levy[18] WLE + RT 37 - Superficial X-rays 88 15–18 5–6 4/37 pts exhibited "fair or poor results"
Enhamre[19] WLE + RT 47 62 Superficial X-rays 88 10–15 1–3 No statistical difference in pts. treated 3 vs 14 days post-excision.
Ogawa[20] WLE + RT 129 147 electrons 67 15 5 Numerically large series with single dose protocol
Klumpar[21] WLE + RT 83 126 Mixed 78 Study demonstrates electron beam offers no advantage over orthovoltage 
therapy
73 Orthovoltage X-
rays
85
53 electrons 79
Maarouf[9] WLE + RT 100 134 electrons 84 9–15 3–5
Malaker[22] RT alone 64 86 Superficial X-
rays/electrons
97 37.5 5 All pts had unresectable keloids; 63% of patients were pleased with 
treatment outcome
Ragoowansi[1
2]
WLE + RT 80 80 Superficial X-rays 84 10 1 100% control at 4 weeks follow-up; 91% relapse free at 1 yr; 84% relapse 
free at 5-years.
Sallstrom[23] WLE + RT 124 - Superficial X-rays 92 18 3 At 24 months 93% of patients found therapy worthwhile.
Sclafani[8] WLE + RT 16 - Superficial X-rays 88 7–10 1 RT arm of randomized trial vs. corticosteroid injection; greater 
compliance and ease of treatment with RT.BMC Dermatology 2006, 6:7 http://www.biomedcentral.com/1471-5945/6/7
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kind for keloids demonstrated greater control rates for
surgical excision and radiotherapy compared to surgery
and corticosteroid injection, with recurrence rates of
12.5% after surgery and radiation therapy, versus 33%
after surgery and steroid injections, though with a statisti-
cally non-significant mean differential [8]. The favorable
outcomes with this approach are attributable to destruc-
tion of keloid fibroblasts by ionizing radiation, which has
been shown to enhance apoptosis when given in small to
moderate doses. In a study by Luo et al., gamma radiation
was found to cause a 2-fold increase in the density of
apoptotic cells in both normal and keloid tissue [13].
According to a study by Ragoowansi et al., using 60 kV
photon irradiation of 10 Gy in a single fraction to treat 80
keloids in 80 patients, the majority of keloids can be con-
trolled by a single operation with immediate adjuvant sin-
gle-fraction radiotherapy [14]. Unresectable keloids can
also be treated satisfactorily with radiotherapy, as Malaker
et al. demonstrated by treating 64 patients with 86 unre-
sectable keloids with 37.5 Gy was given in 5 fractions over
a 5-week period[15]. By 18 months 97% of patients had
complete regression and 3% had partial regression. Sur-
veyed, 63% of patients were happy with the outcome.
Additional series have concurred that recurrent keloids
may be successfully treated with the radiotherapy post-
excision [16], and have also explored brachytherapy as an
option for patients failing primary therapy [17]. Electron
radiotherapy has also been used with good result. Maar-
ouf et al. report a series of 134 keloids treated following
surgical excision, with an 84% control rate) and minimal
side effects, with a mean follow-up period of 7.2 years [9].
Ogawa et al followed 129 keloid cases for 18 or more
months after post-operative irradiation with 4-MeV elec-
tron beam radiation of 15 Gy [19]. With a median follow-
up period of 24 months, there was an overall 32.7% recur-
rence rate. The most common side effects of radiotherapy
consist of hyperpigmentation, pruritis, and erythema.
Additionally, there is a small, but notable, stochastic risk
for future secondary malignancy inherent in any radiation
exposure. However, at present, few series have exhibited
notable secondary carcinogenesis[10]; Dinh et al. [11]
note that in a cumulative review by Ragoowansi [12] five
(5) possible secondary malignancies were noted in 6,741
treated keloids, for crude risk of 1/1,348 patients, accord-
ing to the literature. Consequently, patients must be
informed and radiotherapy used judiciously, and with
careful follow-up of patients over the course of their lives.
While no optimum treatment modality has been demon-
strated for recurrent keloids in adults, surgical resection
and adjuvant radiation therapy may provide an effective
option, with notable clinical success rates. In summary,
radiotherapy is, while not without risk, an exceedingly
effective primary adjuvant or salvage therapy for some kel-
oids (particularly large and recurrent tumors). Radiother-
apy has been shown in extant series to exhibit better
results than the other notable adjuvant therapy of choice,
corticosteroid injection [8], with a secondary malignancy
risk that is minimal enough such that it should not pre-
clude utilization [10,11].
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